Drug Safety Research Unit (DSRU), Southampton, UKSouthampton, UK, United Kingdom
Disclosure information not submitted.
5D-02 - Assessing a Signal of Congenital Anomalies Following Dydrogesterone Exposure in Pregnancy: Results From a Disproportionality Analysis (DPA) and Systematic Review
Tuesday, August 26, 20258:45 AM - 9:00 AM ET